Epitope Inc. announced on Wednesday an $8.06 million privateplacement with European institutions. The Beaverton, Ore.,company (ASE:EPT) said it issued about 2.9 million warrants topurchase Epitope common stock for $14.88 per share. Thewarrants will expire either 120 days after FDA approves thecompany's OraSure oral specimen collection device for HIV-1screening, 120 days after the average trading price of thecompany's stock has traded at at least $30 for 20 consecutivetrading days, or Dec. 23, 1997, whichever comes first.
Epitope stock closed Wednesday at $16.63 a share, up 38 cents.
(c) 1997 American Health Consultants. All rights reserved.